Publications by authors named "Setsuko Ueno"

Article Synopsis
  • A recent study explored a quick 3-minute eye tracking test as a method to assess cognitive function in normal control subjects (NC), those with mild cognitive impairment (MCI), and Alzheimer's disease (AD).
  • Results showed significant declines in eye tracking scores for MCI and AD patients compared to NC, with the test correlating well with traditional cognitive assessments like the mini-mental state examination (MMSE).
  • The eye tracking test was effective in distinguishing between NC, MCI, and AD, highlighting its potential for early detection of cognitive impairments.
View Article and Find Full Text PDF

Due to the rapid increase in traffic accidents caused by the old populations of ages 65-74 and more than 75 in Japan, the renewal of driver's licenses has become more difficult following the revision of traffic laws in March 2017. As part of the driver's license clinic at Kurashiki Heisei Hospital, the present study investigated the status of voluntary license surrender in Okayama Prefecture of Japan. From March 2017 to December 2019, the number of voluntary surrenders increased from 5,434 to 10,284 cases, or at a rate of 0.

View Article and Find Full Text PDF

Following the passage of a new traffic law in March 2017, an inquiry survey was performed for 202 patients (men 60.9%, women 39.1%) in a medical center for neurocognitive disorders in Japan.

View Article and Find Full Text PDF

Oxidative stress is part of the entire pathological process that underlies the development of Alzheimer's disease (AD), including the mild cognitive impairment (MCI) stage. Twendee X (TwX) is a supplement containing a strong antioxidative mix of eight antioxidants, which has been shown to have a clinical and therapeutic benefit in AD model mice. Here, we conducted a multicenter, randomized, double-blind, and placebo-controlled prospective interventional study to evaluate the efficacy of TwX in mitigating MCI.

View Article and Find Full Text PDF

An increased risk of second malignancy is well recognized in patients treated for plasma cell neoplasms. However, second solid tumor is very rare in such patients. We report a case of a 68-year-old woman with plasmacytoma who developed lung adenocarcinoma.

View Article and Find Full Text PDF